Link copied 
Longenesis, a Latvian fintech service provider, has collaborated with two major South Korean health providers to integrate blockchain-based medical consent platform.
As per its press release, the company will offer its medical-consent platform, built using Bitfury’s enterprise-grade blockchain framework Exonum, to Hanshin Medipia Medical Center and Infinity Care. Following the deal, Longenesis extends its list of South Korean partnerships to four, including Gil Medical Center and Insilico Medicine.
Founded in 2017, the company offers modular blockchain solutions for medical providers using a novel operational framework to supply everything, from user interfaces for patient interaction to medical recordkeeping systems. However, its current focus now is on creating medical-consent technologies.
“Our platform is designed for any medical institution interested in building a more transparent and trusting relationship with their patients while also helping more medical data become available for crucial research,” Garri Zmudze, Longenesis CEO, said.
Under the deal, Longenesis will help its new partners meet data compliance requirements for both foreign and local patients. Specifically, it will be compliant with the Health Insurance Portability and Accountability Act (HIPAA) and General Data Protection Regulation (GDPR).
In addition, its extended blockchain toolkit, which is composed of consent management tool, a B2C interface, quality assessment module, and patient dashboard, will help simplify the onboarding and continuing care processes of patients.
The blockchain platform will help both medical institutions track and manage user consent, achieve faster direct patient communication, evaluate treatment quality of their patients in real-time, and search among anonymized metadata for research and clinical trials.
“We believe, through this partnership, that both Hanshin Medipia Medical Center and Infinity Care will be able to improve the quality and efficiency of their services, as well as increase the quality and quantity of data available for R&D and drug development,” Zmudze said.
Bitfury announced its collaboration with Longenesis to launch a blockchain-based consent management system for the healthcare industry last April.
